VSVisaSignalOfficial filing intelligence

LCA activity

Novartis Pharmaceuticals H-1B/LCA filings

Recent labor-condition rows help reveal roles, worksites, wages, and case statuses. LCA certification is not USCIS petition approval.

View PERM

Imported LCA rows

62

Median wage

$143,250

Source period

FY2026 Q2

H-1B/LCA filing signal: As of source verification 2026-06-25, Novartis Pharmaceuticals shows 62 imported DOL labor-condition rows through FY2026 Q2 on VisaSignal. The largest role bucket is Principal Biostatistician (9 rows). The largest worksite bucket is East Hanover, NJ (61 rows). Treat this as historical H-1B/LCA filing activity, not proof of USCIS petition approval or future sponsorship.

Wage range

Novartis Pharmaceuticals H-1B reported wage range

Normalized from 72 imported LCA wage rows. DOL-disclosed offered and prevailing wages span different roles, worksites, and wage units — read the band as wage-distribution context, not a guaranteed offer or legal minimum.

25th percentile

$122,450

Median

$143,250

75th percentile

$175,781

Range

$73,195 – $227,000

H-1B evidence checklist

How to use this Novartis Pharmaceuticals LCA evidence

For searches like "Novartis Pharmaceuticals H-1B", "Novartis Pharmaceuticals LCA", or "does Novartis Pharmaceuticals sponsor H-1B", read the filing count, role/worksite pattern, and status mix together before treating the employer as a lead.

Start with the official LCA count

For "Novartis Pharmaceuticals H-1B" or "Novartis Pharmaceuticals LCA" research, 62 imported DOL LCA rows through FY2026 Q2 show labor-condition activity attributed to this normalized employer name. Use the count as a historical filing signal, not a hiring promise.

Read source caveats

Check role and worksite fit

Principal Biostatistician (9 rows) and East Hanover, NJ (61 rows) are the strongest role and worksite signals. Compare those row-level patterns with the wage band before treating Novartis Pharmaceuticals as relevant to your target role or location.

Compare salary signals

Separate DOL certification from USCIS approval

Certified represents 100% of the displayed LCA rows. DOL LCA certification is not USCIS H-1B petition approval, so read the status mix with row dates and source period before treating Novartis Pharmaceuticals as a sponsor lead. Then compare the employer against the broader H-1B sponsor database before shortlisting.

Browse H-1B sponsors

Open the row-level LCA lookup

Use the full LCA and PERM database lookup when you need to search Novartis Pharmaceuticals rows across job titles, SOC codes, worksites, and states instead of relying only on this employer summary.

Open LCA database lookup

LCA query context

How to read Novartis Pharmaceuticals LCA results

For searches like "Novartis Pharmaceuticals LCA", start with the official filing count, then compare role, worksite, wage, and status signals before opening individual rows.

Role signal

Principal Biostatistician is the largest imported role bucket with 9 matching rows.

Status signal

Certified is the largest observed case-status bucket, representing 100% of 62 displayed LCA rows.

Status mix is the share of displayed official DOL LCA rows by case outcome; for Novartis Pharmaceuticals, Certified accounts for 100% of the recent LCA rows shown here as of source verification .

LCA case rows with status, decision date, role, worksite, wage, and source period
CaseStatusDecisionRoleWorksiteWageSource
I-200-26083-724939CertifiedMar 31, 2026Clinical Trial Leader IEast Hanover, NJ$141,398FY2026 Q2
I-200-26083-725904CertifiedMar 31, 2026AD, Patient and Provider Analytics - CRMEast Hanover, NJ$169,541FY2026 Q2
I-200-26083-724844CertifiedMar 31, 2026Principal BiostatisticianEast Hanover, NJ$112,965FY2026 Q2
I-200-26083-725059CertifiedMar 31, 2026Finance ManagerEast Hanover, NJ$73,195FY2026 Q2
I-200-26083-725458CertifiedMar 31, 2026Associate Director, Patient & Provider AnalyticsEast Hanover, NJ$169,541FY2026 Q2
I-200-26083-724794CertifiedMar 31, 2026Expert CMC StatisticsEast Hanover, NJ$112,965FY2026 Q2
I-200-26083-725980CertifiedMar 31, 2026Senior Principal StatisticianEast Hanover, NJ$112,965FY2026 Q2
I-200-26082-722422CertifiedMar 30, 2026Associate Clinical Development Medical DirectorEast Hanover, NJ$116,730FY2026 Q2
I-200-26082-722480CertifiedMar 30, 2026Principal BiostatisticianEast Hanover, NJ$112,965FY2026 Q2
I-200-26079-719490CertifiedMar 27, 2026Principal BiostatisticianEast Hanover, NJ$112,965FY2026 Q2
I-200-26079-719471CertifiedMar 27, 2026Principal BiostatisticianEast Hanover, NJ$112,965FY2026 Q2
I-200-26079-719544CertifiedMar 27, 2026Principal BiostatisticianEast Hanover, NJ$112,965FY2026 Q2
I-200-26079-719246CertifiedMar 27, 2026Study LeaderEast Hanover, NJ$141,398FY2026 Q2
I-200-26079-719436CertifiedMar 27, 2026Associate Director, PSC Operations InsightsEast Hanover, NJ$169,541FY2026 Q2
I-200-26079-719296CertifiedMar 27, 2026Director, Product Strategy CounselEast Hanover, NJ$156,832FY2026 Q2
I-200-26079-719371CertifiedMar 27, 2026AD, Integrated Field Execution Effectiveness - CEEast Hanover, NJ$169,541FY2026 Q2
I-200-26078-714738CertifiedMar 26, 2026Principal BiostatisticianEast Hanover, NJ$112,965FY2026 Q2
I-200-26078-714702CertifiedMar 26, 2026Director, Forecasting-CVEast Hanover, NJ$169,541FY2026 Q2
I-200-26078-715666CertifiedMar 26, 2026Expert Science & TechnologyEast Hanover, NJ$96,054FY2026 Q2
I-200-26078-714721CertifiedMar 26, 2026Associate Expert PotencyEast Hanover, NJ$89,419FY2026 Q2
I-200-26078-715164CertifiedMar 26, 2026Principal BiostatisticianCambridge, MA$89,731FY2026 Q2
I-200-26077-713989CertifiedMar 25, 2026Director, Emerging Data Products - NSEast Hanover, NJ$223,642FY2026 Q2
I-200-26077-711495CertifiedMar 25, 2026Head of Strategy, USEast Hanover, NJ$223,142FY2026 Q2
I-200-26077-713980CertifiedMar 25, 2026Associate Director, Business Performance - CRMEast Hanover, NJ$169,541FY2026 Q2
I-200-26077-713437CertifiedMar 25, 2026Operational Health Project ManagerEast Hanover, NJ$129,709FY2026 Q2
I-200-26077-713499CertifiedMar 25, 2026FDP AssociateEast Hanover, NJ$112,778FY2026 Q2
I-200-26069-692117CertifiedMar 17, 2026Technology Product DirectorEast Hanover, NJ$223,642FY2026 Q2
I-200-26068-688719CertifiedMar 16, 2026Director, Integrated Field Targeting and NBA - CEEast Hanover, NJ$169,541FY2026 Q2
I-200-26051-655231CertifiedFeb 27, 2026Senior Product Manager - Novartis Patient SupportEast Hanover, NJ$126,818FY2026 Q2
I-200-26041-632070CertifiedFeb 18, 2026Associate Director, Monitoring and StandardsEast Hanover, NJ$169,541FY2026 Q2
I-200-26006-536924CertifiedJan 13, 2026Senior Principal Product Service ManagerEast Hanover, NJ$126,818FY2026 Q2
I-200-26006-536830CertifiedJan 13, 2026Global Regulatory Submission ManagerEast Hanover, NJ$141,190FY2026 Q2
I-200-25353-498907CertifiedDec 29, 2025Director, Resource Optimization CommercialEast Hanover, NJ$223,142FY2026 Q1
I-200-25353-498907CertifiedDec 29, 2025Director, Resource Optimization CommercialEast Hanover, NJ$223,142FY2026 Q2
I-200-25344-473590CertifiedDec 17, 2025Director, Resource Optimization CommercialEast Hanover, NJ$223,142FY2026 Q2
I-200-25344-473826CertifiedDec 17, 2025Director, AI Use Case LeadEast Hanover, NJ$185,723FY2026 Q1
I-200-25344-473826CertifiedDec 17, 2025Director, AI Use Case LeadEast Hanover, NJ$185,723FY2026 Q2
I-200-25344-473590CertifiedDec 17, 2025Director, Resource Optimization CommercialEast Hanover, NJ$223,142FY2026 Q1
I-200-25329-438434CertifiedDec 3, 2025Director - Decision Science, Immunology Product LeadEast Hanover, NJ$138,466FY2026 Q1
I-200-25329-438434CertifiedDec 3, 2025Director - Decision Science, Immunology Product LeadEast Hanover, NJ$138,466FY2026 Q2
I-200-25325-430549CertifiedDec 1, 2025BPO Order Management & Finance, C&GEast Hanover, NJ$169,541FY2026 Q2
I-200-25325-430549CertifiedDec 1, 2025BPO Order Management & Finance, C&GEast Hanover, NJ$169,541FY2026 Q1
I-200-25323-423451CertifiedNov 26, 2025Product Strategy Lead, Stroke Prevention in A-FibEast Hanover, NJ$199,410FY2026 Q1
I-200-25323-423451CertifiedNov 26, 2025Product Strategy Lead, Stroke Prevention in A-FibEast Hanover, NJ$199,410FY2026 Q2
I-200-25316-402734CertifiedNov 19, 2025Expert Science & TechnologyCambridge, MA$122,450FY2026 Q1
I-200-25316-402734CertifiedNov 19, 2025Expert Science & TechnologyCambridge, MA$122,450FY2026 Q2
I-200-25315-399038CertifiedNov 18, 2025Senior Principal BiostatisticianCambridge, MA$127,858FY2026 Q2
I-200-25315-399038CertifiedNov 18, 2025Senior Principal BiostatisticianCambridge, MA$127,858FY2026 Q1
I-200-25311-387470CertifiedNov 17, 2025Associate Director, Integrated Field Targeting & NBAEast Hanover, NJ$169,541FY2026 Q1
I-200-25311-387470CertifiedNov 17, 2025Associate Director, Integrated Field Targeting & NBAEast Hanover, NJ$169,541FY2026 Q2
I-200-25307-364234CertifiedNov 14, 2025Associate Director, BiostatisticsEast Hanover, NJ$175,781FY2026 Q1
I-200-25308-368990CertifiedNov 14, 2025ED, Portfolio & Early Pipeline StrategyEast Hanover, NJ$199,410FY2026 Q1
I-200-25307-364234CertifiedNov 14, 2025Associate Director, BiostatisticsEast Hanover, NJ$175,781FY2026 Q2
I-200-25307-366373CertifiedNov 14, 2025AD, Integrated Field Deployment & GTM AnalyticsEast Hanover, NJ$139,506FY2026 Q1
I-200-25308-368990CertifiedNov 14, 2025ED, Portfolio & Early Pipeline StrategyEast Hanover, NJ$199,410FY2026 Q2
I-200-25307-366373CertifiedNov 14, 2025AD, Integrated Field Deployment & GTM AnalyticsEast Hanover, NJ$139,506FY2026 Q2
I-200-25304-353043CertifiedNov 7, 2025Expert Science & TechnologyDurham, NC$112,757FY2026 Q1
I-200-25304-353043CertifiedNov 7, 2025Expert Science & TechnologyDurham, NC$112,757FY2026 Q2
I-200-25272-340819CertifiedNov 6, 2025Principal BiostatisticianCambridge, MA$127,858FY2026 Q2
I-200-25272-343198CertifiedNov 6, 2025Manager, HCP Education DeliveryEast Hanover, NJ$143,250FY2026 Q1
I-200-25272-343198CertifiedNov 6, 2025Manager, HCP Education DeliveryEast Hanover, NJ$143,250FY2026 Q2
I-200-25272-340819CertifiedNov 6, 2025Principal BiostatisticianCambridge, MA$127,858FY2026 Q1

Related sponsors

Sponsors adjacent to Novartis Pharmaceuticals

Employers with imported DOL LCA or PERM filings that also list New Jersey worksites, weighted toward overlapping roles. Shared filing footprints are a research and discovery signal, not a hiring or sponsorship guarantee.

Primary source

Where this LCA filing signal comes from

LCA rows for Novartis Pharmaceuticals are imported from DOL OFLC LCA Disclosure Data, the official US Department of Labor disclosure dataset. See About data for source caveats and Source status for import freshness, or use the LCA and PERM database lookup to search records across employers, roles, SOC codes, cities, and states. To check whether a different company sponsors H-1B, run it through the H-1B sponsor checker or review the H-1B sponsor cost guide.

DOL OFLC performance page

Date retrieved: . Last verified: . Page updated: .

FAQ

Common questions

What does Novartis Pharmaceuticals LCA mean on VisaSignal?

The Novartis Pharmaceuticals LCA page summarizes imported Department of Labor labor-condition rows for this normalized employer, including roles, worksites, wages, case statuses, and source periods.

Is Novartis Pharmaceuticals LCA activity the same as H-1B approval?

No. LCA certification is an official DOL labor-condition filing signal, but USCIS decides H-1B petitions separately. Use the page as employer research context, not as an approval record.

Is Novartis Pharmaceuticals an H-1B sponsor?

Searches like "Novartis Pharmaceuticals H-1B" or "Novartis Pharmaceuticals H-1B sponsor" are best read against this LCA filing activity, which reflects historical labor-condition signals at Novartis Pharmaceuticals. It is not a promise of future sponsorship or an indicator of any individual case outcome.

Can I use this as a Novartis Pharmaceuticals LCA lookup?

Yes. This Novartis Pharmaceuticals LCA lookup view shows imported official DOL labor-condition rows for the employer, including job titles, worksites, wage fields, case statuses, and source periods. For a broader LCA lookup across employers, roles, SOC codes, cities, and states, use the LCA and PERM database lookup.

What H-1B salary range does Novartis Pharmaceuticals report?

For searches like "Novartis Pharmaceuticals H-1B salary", VisaSignal normalizes the imported LCA wage fields into a range — the 25th-to-75th-percentile band plus the lowest and highest observed values — instead of a single number. These are DOL-disclosed offered and prevailing wages spanning different roles, worksites, and wage units, so read the band as wage-distribution context, not a guaranteed offer or legal minimum.

Does an LCA certification mean an H-1B petition was approved?

No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.

Does a PERM certification mean a green card was approved?

No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.

Can this data prove an employer will sponsor a candidate?

No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.

LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.